ILMN
Illumina, Inc (ILMN) Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Illumina advances preventive genomics through strategic consortium with Veritas Genetics
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Alliance For Genomic Discovery Expands With Regeneron Genetics Center Membership And New Proteomics Data Offering
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Illumia Unveils New Brand Identity at Momentum Conference, Announces 2026 Distinction Award Winners
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Illumina launches TruPath Genome, setting a new standard in genomic insight
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Illumina Unveils Roadmap Of Groundbreaking Novaseq X Advancements In Data Quality, Output, Speed, And Flexibility
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Q4 2025 Earnings Call
Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Conference
Illumina, Inc (ILMN) Q4 2025 Earnings Call
Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Conference